Jane Street’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Jane Street’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-99,324	Closed	-$28K	–	10556
2022 Q3	$28K	Buy	99,324 +6,879	+7%	+$2.36K	﹤0.01%	9115
2022 Q2	$33K	Buy	+92,445	New	+$38.3K	﹤0.01%	9035
2022 Q1	–	Sell	-23,259	Closed	-$30K	–	11346
2021 Q4	$30K	Buy	+23,259	New	+$41.3K	﹤0.01%	9700
2021 Q1	–	Sell	-11,588	Closed	-$32K	–	9771
2020 Q4	$32K	Buy	+11,588	New	+$33.7K	﹤0.01%	7354
2019 Q3	–	Sell	-46,455	Closed	-$289K	–	5966
2019 Q2	$289K	Buy	46,455 +41,945	+930%	+$319K	﹤0.01%	4242
2019 Q1	$48K	Buy	+4,510	New	+$44.9K	﹤0.01%	4836
2018 Q3	–	Sell	-19,379	Closed	-$350K	–	5884
2018 Q2	$350K	Buy	+19,379	New	+$286K	﹤0.01%	3971
2018 Q1	–	Sell	-2,650	Closed	-$112K	–	5601
2017 Q4	$112K	Sell	2,650 -790	-23%	-$35.4K	﹤0.01%	4328
2017 Q3	$189K	Buy	+3,440	New	+$580K	﹤0.01%	4152

Other funds holding SIOX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

TVWM

Tower View Wealth Management Shorewood, Wisconsin $195M AUM 29.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street's SIOX Position: Q4 2022 in Review

Jane Street sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2022, closing a stake of 99,324 shares — an estimated $28K sold.

Jane Street first reported a position in SIOX in Q3 2017 and held it in 9 quarters. The position peaked at $350K in Q2 2018. 37 funds tracked by Wall St. Rank hold SIOX as of Q4 2022.

Jane Street reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Jane Street sold 99,324 Sio Gene Therapies Inc. Common Stock shares in Q4 2022, an estimated $28K.
Jane Street first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Jane Street's Sio Gene Therapies Inc. Common Stock position peaked at $350K in Q2 2018.
37 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.